Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 5, 2013

Presepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsis

  • Tatjana Vodnik EMAIL logo , Goran Kaljevic , Tanja Tadic and Nada Majkic-Singh

Abstract

Background: The aim of the study was to identify the diagnostic significance of presepsin in acute abdominal conditions and also to examine the correlation between presepsin, procalcitonin (PCT) and other parameters.

Methods: To detect presepsin we used a new rapid method based on a chemiluminescent enzyme immunoassay. The clinical usefulness of presepsin to differentiate bacterial and non-bacterial infection [including systemic inflammation response syndrome (SIRS)] was studied and compared with PCT, C-reactive protein (CRP) and white blood cells (WBC).

Results: The presepsin values in different conditions were (mean±standard deviation): healthy group (n=70) 258.7±92.53 pg/mL; SIRS (n=30) 430.0±141.33 pg/mL; sepsis (n=30) 1508.3±866.6 pg/mL. The presepsin values were significantly higher in patients with sepsis than the SIRS group (p<0.0001, Mann-Whitney U-test). The area under the receiver operating characteristics (ROC) curve (AUC) for discriminating of the SIRS from the sepsis patients was 0.996 for presepsin and it was greater than the AUC of PCT (0.912), CRP (0.857) or WBC (0.777).

Conclusions: The ROC curve of the SIRS patient without infection and the sepsis patient showed that the presepsin concentration was a significantly sensitive indicator of sepsis and useful marker for the rapid diagnosis of sepsis.


Corresponding author: Prim MSc Tatjana Vodnik, Center for Medical Biochemistry, Clinical Center of Serbia, Višegradska 26, 11000 Belgrade, Serbia, E-mail:

References

1. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. International Sepsis Definitions Conference, 2001 SCCM/ESICM/ACCP/ATS/SIS. Intensive Care Med 2003;29:530–8.10.1007/s00134-003-1662-xSearch in Google Scholar

2. Dellinger RP, Levy MM, Carlet JM. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2008;36:296–327.10.1097/01.CCM.0000298158.12101.41Search in Google Scholar PubMed

3. Longo DL, Fauci AS, Kasper DL, Hauser SL. Harrison′s principles of internal medicine, 18th ed. New York: McGraw-Hill Medical, 2011.Search in Google Scholar

4. Kortgen A, Niederprum P, Bauer M. Implementation of an evidence-based standard operating procedures and outcome in septic shock. Crit Care Med 2006;34:943–9.10.1097/01.CCM.0000206112.32673.D4Search in Google Scholar

5. Nguyen HB, Corbett SW, Steele R, Banta J, Clark RT, Hayes SR. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med 2007;35:1105–12.10.1097/01.CCM.0000259463.33848.3Dhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000245302400015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

6. Suffredini AF, Munford RS. Novel therapies for septic shock over the past 4 decades. J Am Med Assoc 2011;306:194–9.10.1001/jama.2011.909http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000292639400027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar

7. Angus DC, Burgner D, Wunderink R, Mira JP, Gerlach H, Wiedermann CJ, et al. The PIRO concept. Crit Care 2003;7:248–51.10.1186/cc2193Search in Google Scholar PubMed

8. Rubulotta F, Marchall JC, Ramsay G, Nelson D, Levy MM, Williams M. Predisposition, insult/infection, response and organ dysfunction: a new model for staging severe sepsis. Crit Care Med 2009;37:1329–35.10.1097/CCM.0b013e31819d5db1Search in Google Scholar PubMed

9. Puylaert JB, van der Zant FM, Rijke AM. Sonography and the acute abdomen: practical considerations. Am J Radiol 1997;168:179–86.10.2214/ajr.168.1.8976943Search in Google Scholar

10. Ventetuolo CE, Levy MM. Biomarkers: diagnosis and risk assessment in sepsis. Clin Chest Med 2008;29:591–603.10.1016/j.ccm.2008.07.001http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000261149600003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

11. Coelho FR, Martins JO. Diagnostic methods in sepsis: the need of speed. Rec Assoc Med Bras 2012;58:498–504.10.1016/S0104-4230(12)70236-1Search in Google Scholar

12. Hall TC, Bilku DK, Al-Leswas D, Horst C, Dennison AR. Biomarkers for the differentiation of sepsis and SIRS: the need for the standardisation of diagnostic studies. Ir J Med Sci 2011;180:793–8.10.1007/s11845-011-0741-1http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000208648700003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

13. Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 2011;66:1133–40.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000288251200005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar

14. Castelli GP, Pognani C, Cita M, Paladini R. Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Crit Care Med 2009;37:1845–9.10.1097/CCM.0b013e31819ffd5bhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000266300300002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

15. Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol 2010;159:253–64.10.1111/j.1476-5381.2009.00433.xhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000273991100001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed PubMed Central

16. Meisner M. PCT, procalcitonin – a new, innovative infection parameter. Stuttgart: Georg Thieme Verlag, 2000.Search in Google Scholar

17. Suberviola B, Castellanos-Ortega A, Gonzales-Castro A. Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock. Med Intensiva 2012;36:177–84.10.1016/j.medin.2011.09.008http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000302921200003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

18. Kojika M, Takahashi G, Matsumoto N, Kikkawa T, Hoshikawa K, Shioya N, et al. Serum levels of soluble CD14 subtype reflect the APACHE II and SOFA Scores. Med Postgrad 2010;48: 46–50.Search in Google Scholar

19. Takahashi G, Suzuki Y, Kojika M, Matsumoto N, Shozushima T, Makabe H, et al. Evaluation of responses to IVIG therapy in patients with severe sepsis and septic shock by soluble CD14 subtype monitoring. Med Postgrad 2010;48:19–24.Search in Google Scholar

20. Spanuth E, Wilhelm J, Loppnow H, Ebelt H, Ivandic B, Werdan K. Diagnostic and prognostic value of presepsin (soluble CD14 subtype) in emergency patients with early sepsis using the new assay PATHFAST presepsin. IFCC World Lab/Euro Med Lab Proceedings 2011.10.1515/9783110224641.128Search in Google Scholar

21. Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S, et al. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of SIRS. J Infect Chemother 2011;17:764–9.10.1007/s10156-011-0254-xhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000298056800005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

22. Yaegashi Y, Shirakawa K, Sato N, Suzuki Y, Kojika M, Imai S, et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother 2005;11:234–8.10.1007/s10156-005-0400-4Search in Google Scholar PubMed

23. Shirakawa K, Naitou K, Hirose J, Takahashi T, Furusako S. Presepsin (sCD14-ST): development and evaluation one-step ELISA with a new standard that is similar to the form of presepsin in septic patients. Clin Chem Lab Med 2011;49: 937–9.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000289465700030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar

24. ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for use of innovate therapies in sepsis. Crit Care Med 1992;20:867–74.Search in Google Scholar

25. Okamura Y, Yokoi H. Development of a point-of-care assay for measurement of presepsin (sCD14-ST). Clinica Chimica Acta 2011;412:2157–61.10.1016/j.cca.2011.07.024http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000296686100023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

26. Dellinger RP, Carlet JN, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004;30:536–55.10.1007/s00134-004-2210-zSearch in Google Scholar PubMed

27. Takahashi G, Suzuki Y, Kojika M, Shozushima T, Matsumoto N, Kikkawa T, et al. Assessment of the usefulness of the soluble CD14 subtype and the point of care test in septic patients. Med Postgrad 2010;48:15–8.Search in Google Scholar

28. Clech C, Fosse JP, Karoubi P, Vincent F, Chouahi I, Cohen Y, et al. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006;34:102–7.10.1097/01.CCM.0000195012.54682.F3Search in Google Scholar

29. Jensen J, Heslet L, Jensen T, Espersen K, Steffensen P, Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006;34:2596–602.10.1097/01.CCM.0000239116.01855.61Search in Google Scholar PubMed

30. Nakamura M, Takeuchi T, Naito K, Shirakawa K, Hosaka Y, Yamasaki F, et al. Early elevation of plasma soluble CD14 subtype, a novel biomarker for sepsis, in rabbit cecal ligation and puncture model. Crit Care 2008;12:P194.10.1186/cc6415Search in Google Scholar

31. Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother 2012;18:891–7.10.1007/s10156-012-0435-2http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000312739400014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

Received: 2013-01-23
Accepted: 2013-05-14
Published Online: 2013-06-05
Published in Print: 2013-10-01

©2013 by Walter de Gruyter Berlin Boston

Downloaded on 28.3.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2013-0061/html
Scroll to top button